Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]

 ANGT_RAT                Reviewed;         477 AA.
P01015;
21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
21-JUL-1986, sequence version 1.
22-NOV-2017, entry version 147.
RecName: Full=Angiotensinogen;
AltName: Full=Serpin A8;
Contains:
RecName: Full=Angiotensin-1;
AltName: Full=Angiotensin 1-10;
AltName: Full=Angiotensin I;
Short=Ang I;
Contains:
RecName: Full=Angiotensin-2;
AltName: Full=Angiotensin 1-8;
AltName: Full=Angiotensin II;
Short=Ang II;
Contains:
RecName: Full=Angiotensin-3;
AltName: Full=Angiotensin 2-8;
AltName: Full=Angiotensin III;
Short=Ang III;
AltName: Full=Des-Asp[1]-angiotensin II;
Contains:
RecName: Full=Angiotensin-4;
AltName: Full=Angiotensin 3-8;
AltName: Full=Angiotensin IV;
Short=Ang IV;
Contains:
RecName: Full=Angiotensin 1-9;
Contains:
RecName: Full=Angiotensin 1-7;
Contains:
RecName: Full=Angiotensin 1-5;
Contains:
RecName: Full=Angiotensin 1-4;
Flags: Precursor;
Name=Agt; Synonyms=Serpina8;
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
NCBI_TaxID=10116;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
STRAIN=Wistar;
PubMed=6572971; DOI=10.1073/pnas.80.8.2196;
Ohkubo H., Kageyama R., Ujihara M., Hirose T., Inayama S.,
Nakanishi S.;
"Cloning and sequence analysis of cDNA for rat angiotensinogen.";
Proc. Natl. Acad. Sci. U.S.A. 80:2196-2200(1983).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=6330095;
Tanaka T., Ohkubo H., Nakanishi S.;
"Common structural organization of the angiotensinogen and the alpha
1-antitrypsin genes.";
J. Biol. Chem. 259:8063-8065(1984).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain, and Kidney;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
PROTEIN SEQUENCE OF 25-34.
PubMed=4344907; DOI=10.1248/cpb.20.1579;
Nakayama T., Nakajima T., Sokabe H.;
"Comparative studies on angiotensins. II. Structure of rat angiotensin
and its identification by DNS-method.";
Chem. Pharm. Bull. 20:1579-1581(1972).
[5]
FUNCTION OF ANGIOTENSIN 1-7.
PubMed=18026570; DOI=10.2119/2007-00073.Fraga-Silva;
Fraga-Silva R.A., Pinheiro S.V.B., Goncalves A.C., Alenina N.,
Bader M., Santos R.A.S.;
"The antithrombotic effect of angiotensin-(1-7) involves mas-mediated
NO release from platelets.";
Mol. Med. 14:28-35(2008).
[6]
X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-477, AND DISULFIDE BOND.
PubMed=20927107; DOI=10.1038/nature09505;
Zhou A., Carrell R.W., Murphy M.P., Wei Z., Yan Y., Stanley P.L.,
Stein P.E., Broughton Pipkin F., Read R.J.;
"A redox switch in angiotensinogen modulates angiotensin release.";
Nature 468:108-111(2010).
-!- FUNCTION: Essential component of the renin-angiotensin system
(RAS), a potent regulator of blood pressure, body fluid and
electrolyte homeostasis. {ECO:0000250}.
-!- FUNCTION: Angiotensin-2: acts directly on vascular smooth muscle
as a potent vasoconstrictor, affects cardiac contractility and
heart rate through its action on the sympathetic nervous system,
and alters renal sodium and water absorption through its ability
to stimulate the zona glomerulosa cells of the adrenal cortex to
synthesize and secrete aldosterone. {ECO:0000250}.
-!- FUNCTION: Angiotensin-3: stimulates aldosterone release.
{ECO:0000250}.
-!- FUNCTION: Angiotensin 1-7: is a ligand for the G-protein coupled
receptor MAS1 (By similarity). Has vasodilator and antidiuretic
effects (By similarity). Has an antithrombotic effect that
involves MAS1-mediated release of nitric oxide from platelets.
{ECO:0000250, ECO:0000269|PubMed:18026570}.
-!- SUBCELLULAR LOCATION: Secreted.
-!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
-!- PTM: In response to low blood pressure, the enzyme renin/REN
cleaves angiotensinogen to produce angiotensin-1. Angiotensin-1 is
a substrate of ACE (angiotensin converting enzyme) that removes a
dipeptide to yield the physiologically active peptide angiotensin-
2. Angiotensin-1 and angiotensin-2 can be further processed to
generate angiotensin-3, angiotensin-4 (By similarity). Angiotensin
1-9 is cleaved from angiotensin-1 by ACE2 and can be further
processed by ACE to produce angiotensin 1-7, angiotensin 1-5 and
angiotensin 1-4. Angiotensin 1-7 has also been proposed to be
cleaved from angiotensin-2 by ACE2 or from angiotensin-1 by MME
(neprilysin) (By similarity). {ECO:0000250}.
-!- PTM: The disulfide bond is labile. Angiotensinogen is present in
the circulation in a near 40:60 ratio with the oxidized disulfide-
bonded form, which preferentially interacts with receptor-bound
renin.
-!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; L00094; AAA98779.1; -; Genomic_DNA.
EMBL; L00091; AAA98779.1; JOINED; Genomic_DNA.
EMBL; L00092; AAA98779.1; JOINED; Genomic_DNA.
EMBL; L00093; AAA98779.1; JOINED; Genomic_DNA.
EMBL; BC078741; AAH78741.1; -; mRNA.
EMBL; BC087679; AAH87679.1; -; mRNA.
PIR; A93945; ANRT.
RefSeq; NP_602308.1; NM_134432.2.
RefSeq; XP_008770819.1; XM_008772597.2.
UniGene; Rn.6319; -.
PDB; 1SMR; X-ray; 2.00 A; B/D/F/H=30-33.
PDB; 2WXZ; X-ray; 2.80 A; A/C=25-477.
PDB; 2WY1; X-ray; 3.15 A; A/B=25-477.
PDBsum; 1SMR; -.
PDBsum; 2WXZ; -.
PDBsum; 2WY1; -.
ProteinModelPortal; P01015; -.
SMR; P01015; -.
MINT; MINT-1522474; -.
STRING; 10116.ENSRNOP00000024917; -.
BindingDB; P01015; -.
MEROPS; I04.953; -.
iPTMnet; P01015; -.
PhosphoSitePlus; P01015; -.
PaxDb; P01015; -.
PRIDE; P01015; -.
Ensembl; ENSRNOT00000024917; ENSRNOP00000024917; ENSRNOG00000018445.
GeneID; 24179; -.
KEGG; rno:24179; -.
UCSC; RGD:2069; rat.
CTD; 183; -.
RGD; 2069; Agt.
eggNOG; KOG2392; Eukaryota.
eggNOG; COG4826; LUCA.
GeneTree; ENSGT00890000139531; -.
HOGENOM; HOG000033941; -.
HOVERGEN; HBG004233; -.
InParanoid; P01015; -.
KO; K09821; -.
OMA; RFMQAVT; -.
OrthoDB; EOG091G077M; -.
PhylomeDB; P01015; -.
TreeFam; TF343201; -.
Reactome; R-RNO-2022377; Metabolism of Angiotensinogen to Angiotensins.
Reactome; R-RNO-375276; Peptide ligand-binding receptors.
Reactome; R-RNO-416476; G alpha (q) signalling events.
Reactome; R-RNO-418594; G alpha (i) signalling events.
EvolutionaryTrace; P01015; -.
PRO; PR:P01015; -.
Proteomes; UP000002494; Chromosome 19.
Bgee; ENSRNOG00000018445; -.
Genevisible; P01015; RN.
GO; GO:0072562; C:blood microparticle; ISO:RGD.
GO; GO:0005737; C:cytoplasm; IDA:RGD.
GO; GO:0070062; C:extracellular exosome; ISO:RGD.
GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
GO; GO:0031701; F:angiotensin receptor binding; IMP:RGD.
GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
GO; GO:0048018; F:receptor ligand activity; ISS:BHF-UCL.
GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:GO_Central.
GO; GO:0031702; F:type 1 angiotensin receptor binding; IMP:RGD.
GO; GO:0031703; F:type 2 angiotensin receptor binding; IMP:RGD.
GO; GO:0007250; P:activation of NF-kappaB-inducing kinase activity; ISO:RGD.
GO; GO:0007202; P:activation of phospholipase C activity; IMP:RGD.
GO; GO:0007568; P:aging; IEP:RGD.
GO; GO:0038166; P:angiotensin-activated signaling pathway; ISS:BHF-UCL.
GO; GO:0003051; P:angiotensin-mediated drinking behavior; IDA:RGD.
GO; GO:0001998; P:angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure; ISO:RGD.
GO; GO:0014824; P:artery smooth muscle contraction; IDA:RGD.
GO; GO:0048143; P:astrocyte activation; ISO:RGD.
GO; GO:0001568; P:blood vessel development; ISO:RGD.
GO; GO:0002035; P:brain renin-angiotensin system; ISO:RGD.
GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
GO; GO:0035411; P:catenin import into nucleus; IDA:RGD.
GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; IDA:RGD.
GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:RGD.
GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
GO; GO:0006883; P:cellular sodium ion homeostasis; IMP:RGD.
GO; GO:0050663; P:cytokine secretion; IDA:RGD.
GO; GO:0042756; P:drinking behavior; ISO:RGD.
GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:RGD.
GO; GO:0008065; P:establishment of blood-nerve barrier; ISO:RGD.
GO; GO:0007588; P:excretion; ISO:RGD.
GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
GO; GO:0007565; P:female pregnancy; IEP:RGD.
GO; GO:0048144; P:fibroblast proliferation; IDA:RGD.
GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:RGD.
GO; GO:0042445; P:hormone metabolic process; ISO:RGD.
GO; GO:0001822; P:kidney development; ISO:RGD.
GO; GO:0016525; P:negative regulation of angiogenesis; IDA:RGD.
GO; GO:0030308; P:negative regulation of cell growth; IMP:RGD.
GO; GO:0008285; P:negative regulation of cell proliferation; ISO:RGD.
GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
GO; GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; ISO:RGD.
GO; GO:0034104; P:negative regulation of tissue remodeling; IDA:RGD.
GO; GO:0001543; P:ovarian follicle rupture; ISO:RGD.
GO; GO:0030432; P:peristalsis; ISO:RGD.
GO; GO:0010536; P:positive regulation of activation of Janus kinase activity; ISO:RGD.
GO; GO:0045777; P:positive regulation of blood pressure; IDA:RGD.
GO; GO:0097755; P:positive regulation of blood vessel diameter; IDA:RGD.
GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISO:RGD.
GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IDA:RGD.
GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IDA:BHF-UCL.
GO; GO:0043085; P:positive regulation of catalytic activity; IMP:RGD.
GO; GO:0008284; P:positive regulation of cell proliferation; IDA:RGD.
GO; GO:0032270; P:positive regulation of cellular protein metabolic process; ISO:RGD.
GO; GO:0010873; P:positive regulation of cholesterol esterification; ISO:RGD.
GO; GO:0050715; P:positive regulation of cytokine secretion; ISO:RGD.
GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; ISO:RGD.
GO; GO:0003331; P:positive regulation of extracellular matrix constituent secretion; IDA:RGD.
GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
GO; GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL.
GO; GO:1903598; P:positive regulation of gap junction assembly; ISO:RGD.
GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
GO; GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IDA:RGD.
GO; GO:1905589; P:positive regulation of L-arginine import across plasma membrane; IDA:RGD.
GO; GO:1905010; P:positive regulation of L-lysine import across plasma membrane; IDA:RGD.
GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:RGD.
GO; GO:0046622; P:positive regulation of organ growth; ISO:RGD.
GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISO:RGD.
GO; GO:1900020; P:positive regulation of protein kinase C activity; ISO:RGD.
GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; ISO:RGD.
GO; GO:0035815; P:positive regulation of renal sodium excretion; IDA:RGD.
GO; GO:0032930; P:positive regulation of superoxide anion generation; IDA:RGD.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL.
GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IDA:RGD.
GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IDA:RGD.
GO; GO:0042981; P:regulation of apoptotic process; IDA:RGD.
GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
GO; GO:0051924; P:regulation of calcium ion transport; IDA:RGD.
GO; GO:1903779; P:regulation of cardiac conduction; ISO:RGD.
GO; GO:1901201; P:regulation of extracellular matrix assembly; ISO:RGD.
GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
GO; GO:0002027; P:regulation of heart rate; IDA:RGD.
GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:RGD.
GO; GO:0014061; P:regulation of norepinephrine secretion; IMP:RGD.
GO; GO:0002019; P:regulation of renal output by angiotensin; ISO:RGD.
GO; GO:0035813; P:regulation of renal sodium excretion; IDA:RGD.
GO; GO:0001991; P:regulation of systemic arterial blood pressure by circulatory renin-angiotensin; ISO:RGD.
GO; GO:0051969; P:regulation of transmission of nerve impulse; IDA:RGD.
GO; GO:0001999; P:renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure; ISO:RGD.
GO; GO:0003014; P:renal system process; ISO:RGD.
GO; GO:0002018; P:renin-angiotensin regulation of aldosterone production; IDA:RGD.
GO; GO:0009409; P:response to cold; ISO:RGD.
GO; GO:0014873; P:response to muscle activity involved in regulation of muscle adaptation; IMP:BHF-UCL.
GO; GO:0009651; P:response to salt stress; ISO:RGD.
GO; GO:0051145; P:smooth muscle cell differentiation; ISO:RGD.
GO; GO:0048659; P:smooth muscle cell proliferation; IDA:RGD.
GO; GO:0051403; P:stress-activated MAPK cascade; IDA:RGD.
GO; GO:0070471; P:uterine smooth muscle contraction; IDA:RGD.
GO; GO:0042310; P:vasoconstriction; IDA:RGD.
GO; GO:0042311; P:vasodilation; IDA:RGD.
InterPro; IPR000227; Angiotensinogen.
InterPro; IPR023796; Serpin_dom.
InterPro; IPR000215; Serpin_fam.
InterPro; IPR036186; Serpin_sf.
PANTHER; PTHR11461; PTHR11461; 1.
PANTHER; PTHR11461:SF13; PTHR11461:SF13; 1.
Pfam; PF00079; Serpin; 1.
PRINTS; PR00654; ANGIOTENSNGN.
SMART; SM00093; SERPIN; 1.
SUPFAM; SSF56574; SSF56574; 1.
1: Evidence at protein level;
3D-structure; Complete proteome; Direct protein sequencing;
Disulfide bond; Glycoprotein; Reference proteome; Secreted; Signal;
Vasoactive; Vasoconstrictor.
SIGNAL 1 24 {ECO:0000269|PubMed:4344907}.
CHAIN 25 477 Angiotensinogen.
/FTId=PRO_0000032468.
PEPTIDE 25 34 Angiotensin-1.
/FTId=PRO_0000032469.
PEPTIDE 25 33 Angiotensin 1-9.
/FTId=PRO_0000420674.
PEPTIDE 25 32 Angiotensin-2.
/FTId=PRO_0000032470.
PEPTIDE 25 31 Angiotensin 1-7.
/FTId=PRO_0000420675.
PEPTIDE 25 29 Angiotensin 1-5.
/FTId=PRO_0000420676.
PEPTIDE 25 28 Angiotensin 1-4.
/FTId=PRO_0000420677.
PEPTIDE 26 32 Angiotensin-3.
/FTId=PRO_0000032471.
PEPTIDE 27 32 Angiotensin-4.
/FTId=PRO_0000420678.
CARBOHYD 295 295 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 319 319 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 42 161 {ECO:0000269|PubMed:20927107}.
TURN 33 35 {ECO:0000244|PDB:2WXZ}.
HELIX 39 43 {ECO:0000244|PDB:2WXZ}.
HELIX 72 84 {ECO:0000244|PDB:2WXZ}.
HELIX 88 115 {ECO:0000244|PDB:2WXZ}.
STRAND 120 124 {ECO:0000244|PDB:2WXZ}.
HELIX 126 138 {ECO:0000244|PDB:2WXZ}.
HELIX 142 151 {ECO:0000244|PDB:2WXZ}.
HELIX 167 181 {ECO:0000244|PDB:2WXZ}.
STRAND 193 203 {ECO:0000244|PDB:2WXZ}.
HELIX 211 216 {ECO:0000244|PDB:2WXZ}.
TURN 217 220 {ECO:0000244|PDB:2WXZ}.
STRAND 224 228 {ECO:0000244|PDB:2WXZ}.
STRAND 231 233 {ECO:0000244|PDB:2WXZ}.
HELIX 235 250 {ECO:0000244|PDB:2WXZ}.
STRAND 267 279 {ECO:0000244|PDB:2WXZ}.
STRAND 282 284 {ECO:0000244|PDB:2WY1}.
STRAND 289 294 {ECO:0000244|PDB:2WXZ}.
STRAND 297 301 {ECO:0000244|PDB:2WXZ}.
STRAND 303 315 {ECO:0000244|PDB:2WXZ}.
TURN 316 319 {ECO:0000244|PDB:2WXZ}.
STRAND 320 340 {ECO:0000244|PDB:2WXZ}.
HELIX 341 343 {ECO:0000244|PDB:2WXZ}.
HELIX 344 351 {ECO:0000244|PDB:2WXZ}.
STRAND 353 355 {ECO:0000244|PDB:2WXZ}.
STRAND 366 373 {ECO:0000244|PDB:2WXZ}.
STRAND 375 382 {ECO:0000244|PDB:2WXZ}.
HELIX 383 389 {ECO:0000244|PDB:2WXZ}.
TURN 393 396 {ECO:0000244|PDB:2WXZ}.
HELIX 403 405 {ECO:0000244|PDB:2WXZ}.
STRAND 406 408 {ECO:0000244|PDB:2WXZ}.
STRAND 416 425 {ECO:0000244|PDB:2WXZ}.
STRAND 452 458 {ECO:0000244|PDB:2WXZ}.
TURN 459 462 {ECO:0000244|PDB:2WXZ}.
STRAND 463 471 {ECO:0000244|PDB:2WXZ}.
SEQUENCE 477 AA; 51982 MW; 689051A5788D693D CRC64;
MTPTGAGLKA TIFCILTWVS LTAGDRVYIH PFHLLYYSKS TCAQLENPSV ETLPEPTFEP
VPIQAKTSPV DEKTLRDKLV LATEKLEAED RQRAAQVAMI ANFMGFRMYK MLSEARGVAS
GAVLSPPALF GTLVSFYLGS LDPTASQLQV LLGVPVKEGD CTSRLDGHKV LTALQAVQGL
LVTQGGSSSQ TPLLQSTVVG LFTAPGLRLK QPFVESLGPF TPAIFPRSLD LSTDPVLAAQ
KINRFVQAVT GWKMNLPLEG VSTDSTLFFN TYVHFQGKMR GFSQLTGLHE FWVDNSTSVS
VPMLSGTGNF QHWSDAQNNF SVTRVPLGES VTLLLIQPQC ASDLDRVEVL VFQHDFLTWI
KNPPPRAIRL TLPQLEIRGS YNLQDLLAQA KLSTLLGAEA NLGKMGDTNP RVGEVLNSIL
LELQAGEEEQ PTESAQQPGS PEVLDVTLSS PFLFAIYERD SGALHFLGRV DNPQNVV


Related products :

Catalog number Product name Quantity
A-1601 Angiotensin A Ala-Angiotensin III, (Ala1)-Angiotensin II 98 percent C49H71N13O10 CAS: 51833-76-2 5mg
orb60743 Enalapril maleate Enalapril maleate(Vasotec ), the active metabolite of enalapril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin 100 mg
B-G-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Biotin labeled purified IgG _ 100ul 100 µl
FR-G-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Rhodamine Labeled Purified IgG _ 100ul 100 µl
T-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Iodine 125 Labeled Tracer _ 10uCi 10 µCi
T-002-28 Angiotensin II (3_8) _ Angiotensin IV (Human, Rat, Mouse, Canine) _ Iodine 125 Labeled Tracer _ 10uCi 10 µCi
G-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Purified IgG Antibody _ 200ug 200 µg
FG-G-002-24A Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ FAM Labeled Purified IgG _ 100ul 100 µl
A-1602-5 (Val5,Asn9)-Angiotensin I Angiotensin I (bullfrog) 98 percent C59H86N16O15 CAS: 5mg
FR-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Rhodamine Labeled _ 1 nmol 1 nmol
FR-002-28 Angiotensin II (3_8) _ Angiotensin IV (Human, Rat, Mouse, Canine) _ Rhodamine Labeled _ 1 nmol 1 nmol
H-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Antibody for Immunohistochemistry _ 50ul 50 µl
H-8125.0025 Angiotensin I_II (3_8) Salt _ Binding _ Synonym Angiotensin IV SumFormula C40H54N8O8 25.0 mg
H-8125.0100 Angiotensin I_II (3_8) Salt _ Binding _ Synonym Angiotensin IV SumFormula C40H54N8O8 100.0 mg
T-G-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Iodine 125 Labeled Purified IgG Tracer _ 10uCi 10 µCi
A-1610-4 (Sar1)-Angiotensin I_II (1-7) amide Angiotensin II antagonist. 98 percent C40H63N13O8 CAS: 126112-22-9 5mg
orb81918 Angiotensin II protein Angiotensin II is a purified hormone_steroid. For research use only. 5 mg
B-002-24A Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Biotin Labeled 20 µg
FG-002-28A Angiotensin II (3_8) _ Angiotensin IV (Human, Rat, Mouse, Canine) _ FAM Labeled _ 1 nmol 1 nmol
FG-002-24A Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ FAM Labeled _ 1 nmol 1 nmol
A-1612 Angiotensin I_II (3-8) Angiotensin IV 98 percent C40H54N8O8 CAS: 23025-68-5 5mg
WBK-002-24 Angiotensin I _ Angiotensin II (1_7)(Human, Rat, Mouse, Canine) _ Western Blot Kit Kit
orb81917 Angiotensin protein Angiotensin is a purified hormone_steroid. For research use only. 1 mg
002-28 Angiotensin II (3_8) _ Angiotensin IV (Human, Rat, Mouse, Canine) _ 200ug 200 µg
002-31 Angiotensin II [Des_Asp1] _ Angiotensin III (Human, Rat, Mouse, Canine) _ 5mg 5 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur